Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Neogenomics Inc
(NQ:
NEO
)
14.64
-0.24 (-1.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neogenomics Inc
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
NeoGenomics Announces Commercial Availability of the RaDaR(R) Molecular Residual Disease Test
March 16, 2023
Via
ACCESSWIRE
NeoGenomics Expands NGS Portfolio with Launch of Neo Comprehensive(TM) - Solid Tumor CGP and Neo Comprehensive(TM) - Myeloid Disorders CGP
March 13, 2023
Via
ACCESSWIRE
Analyst Ratings for NeoGenomics
March 03, 2023
Via
Benzinga
NeoGenomics to Present at the 44th Annual Raymond James Institutional Investors Conference
February 28, 2023
Via
ACCESSWIRE
Cowen & Co. Maintains Outperform Rating for NeoGenomics: Here's What You Need To Know
February 24, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
February 24, 2023
Via
Benzinga
Why Shares of NeoGenomics Jumped Today
February 23, 2023
The company released promising earnings results.
Via
The Motley Fool
Crude Oil Rises 1.5%; NeoGenomics Shares Spike Higher
February 23, 2023
U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded down 0.03% to 33,036.50 while the NASDAQ rose 0.46% to...
Via
Benzinga
Why NeoGenomics Shares Are Trading Higher Today
February 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 23, 2023
Via
Benzinga
US Stocks Turn Lower; Dow Drops 150 Points
February 23, 2023
U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 150 points on Thursday. The Dow traded down 0.47% to 32,889.30 while the NASDAQ fell 0.47% to 11,452.63. The S&P 500...
Via
Benzinga
NeoGenomics Reports Fourth Quarter and Full Year 2022 Results
February 23, 2023
Via
ACCESSWIRE
Analyst Expectations for NeoGenomics's Future
February 01, 2023
Via
Benzinga
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 23, 2023
Gainers
Via
Benzinga
Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday
February 23, 2023
U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Earnings Scheduled For February 23, 2023
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of NeoGenomics Laboratories, Inc. (NEO) Investigation
February 08, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
NeoGenomics, Inc. (NASDAQ:NEO) Investor Notice: Deadline in Lawsuit on February 6, 2023
February 06, 2023
San Diego, CA -- (SBWIRE) -- 02/06/2023 -- The Shareholders Foundation announced that a deadline is coming up on February 6, 2023 in the lawsuit filed for certain investors of NeoGenomics, Inc....
Via
SBWire
NEO FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors to Secure Counsel Before Important February 6 Deadline in Securities Class Action - NEO
February 06, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies NeoGenomics, Inc. (NEO) Investors of Class Action and to Actively Participate
February 06, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
NeoGenomics Schedules its Fourth Quarter and Full Year 2022 Earnings Release for February 23, 2023
February 06, 2023
Via
ACCESSWIRE
RaDaR(R) Assay Demonstrates Clinical Potential for Helping Oncologists Determine Whether or Not Muscle-Invasive Bladder Cancer Patients Undergo Radical Surgery
February 06, 2023
Via
ACCESSWIRE
NEO DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 6 Deadline in Securities Class Action - NEO
February 04, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
NEOGENOMICS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess Of $100,000 of Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO
February 03, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
NEOGENOMICS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against NeoGenomics, Inc. and Encourages Investors to Contact the Firm
February 03, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against F45 Training, Silvergate, NeoGenomics, and Iris and Encourages Investors to Contact the Firm
February 03, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NeoGenomics, Inc. (NEO)
February 03, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
NEO FINAL DEADLINE NOTICE: ROSEN, A LEADING AND RANKED FIRM, Encourages NeoGenomics, Inc. Investors with Losses to Secure Counsel Before Important February 6 Deadline in Securities Class Action - NEO
February 02, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
February 01, 2023
Via
Benzinga
NEO FINAL DEADLINE NOTICE: ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages NeoGenomics, Inc. Investors with Losses to Secure Counsel Before Important February 6 Deadline in Securities Class Action - NEO
January 31, 2023
WHY: NEW YORK, NY - (NewMediaWire) - January 31, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of NeoGenomics, Inc. (NASDAQ: NEO) between February 27,...
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.